Mardi Dier Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mardi Dier.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mardi Dier. Mardi Dier is EVP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and EVP, CFO & CBO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Executive VP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Interim Co-President & CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Senior VP and CFO in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Adamas Pharmaceuticals Inc ($ADMS) and CFO & Executive Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Oric Pharmaceuticals, Inc. ($ORIC).
Latest Insider Trading Transactions of Mardi Dier
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMS, ORIC, PTLA, PRLD, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | PRLD | Prelude Therapeuti ... | Dier Mardi | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Grant | A | 0.00 | 5,500 | 0 | 45,500 | 40 K to 45.5 K (+13.75 %) |
| Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Option Exercise | A | 95.50 | 40,000 | 3,820,000 | 40,000 | |
| Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | Dier Mardi | Director | Buy | P | 19.00 | 10,000 | 190,000 | 10,000 | 0 to 10 K |
| Sep 28 2020 | PRLD | Prelude Therapeuti ... | Dier Mardi | Director | Option Exercise | A | 19.00 | 3,458 | 65,702 | 3,458 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
| Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Dier Mardi | Director | Option Exercise | A | 16.00 | 33,250 | 532,000 | 33,250 | |
| Feb 26 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | A | 0.00 | 73,125 | 0 | 73,125 | |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | A | 12.79 | 65,000 | 831,350 | 65,000 | |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 12.89 | 3,435 | 44,277 | 81,533 | 85 K to 81.5 K (-4.04 %) |
| Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 16,250 | 0 | 84,968 | 68.7 K to 85 K (+23.65 %) |
| Jan 14 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 13.80 | 1,277 | 17,623 | 68,718 | 70 K to 68.7 K (-1.82 %) |
| Jan 14 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 13.80 | 1,277 | 17,623 | 68,718 | 70 K to 68.7 K (-1.82 %) |
| Jan 14 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 2,125 | 0 | 69,995 | 67.9 K to 70 K (+3.13 %) |
| Jan 14 2020 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 2,125 | 0 | 69,995 | 67.9 K to 70 K (+3.13 %) |
| Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | M | 0.00 | 5,859 | 0 | 0 | |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 28.69 | 3,022 | 86,701 | 69,570 | 72.6 K to 69.6 K (-4.16 %) |
| May 21 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 5,859 | 0 | 72,592 | 66.7 K to 72.6 K (+8.78 %) |
| Apr 08 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Sell | S | 37.39 | 40,486 | 1,513,824 | 66,733 | 107.2 K to 66.7 K (-37.76 %) |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Option Exercise | A | 27.10 | 75,000 | 2,032,500 | 75,000 | |
| Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 18,750 | 0 | 116,682 | 97.9 K to 116.7 K (+19.15 %) |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Payment of Exercise | F | 24.25 | 868 | 21,049 | 97,932 | 98.8 K to 97.9 K (-0.88 %) |
| Jan 15 2019 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP, CFO & CBO | Grant | A | 0.00 | 2,125 | 0 | 98,800 | 96.7 K to 98.8 K (+2.20 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Payment of Exercise | F | 29.18 | 8,884 | 259,203 | 98,800 | 107.7 K to 98.8 K (-8.25 %) |
| Sep 05 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 107,684 | 90.2 K to 107.7 K (+19.40 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Payment of Exercise | F | 26.05 | 8,794 | 229,084 | 107,477 | 116.3 K to 107.5 K (-7.56 %) |
| Aug 28 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Interim Co-Presiden ... | Buy | M | 0.00 | 17,500 | 0 | 116,271 | 98.8 K to 116.3 K (+17.72 %) |
| Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 40.82 | 2,514 | 102,621 | 116,271 | 118.8 K to 116.3 K (-2.12 %) |
| May 24 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 5,859 | 0 | 118,785 | 112.9 K to 118.8 K (+5.19 %) |
| Mar 12 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | D | 39.16 | 2,009 | 78,667 | 61,442 | 63.5 K to 61.4 K (-3.17 %) |
| Mar 12 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | D | 38.69 | 10,465 | 404,865 | 63,451 | 73.9 K to 63.5 K (-14.16 %) |
| Mar 06 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 32.53 | 6,735 | 219,090 | 31,040 | 37.8 K to 31 K (-17.83 %) |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | A | 51.31 | 42,500 | 2,180,675 | 42,500 | |
| Feb 02 2018 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 10,625 | 0 | 10,625 | 0 to 10.6 K |
| Oct 11 2017 | ADMS | Adamas Pharmaceuti ... | Dier Mardi | Director | Option Exercise | A | 21.69 | 30,000 | 650,700 | 30,000 | |
| Aug 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 54.86 | 3,635 | 199,416 | 0 | 3.6 K to 0 (-100.00 %) |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 25.08 | 23,350 | 585,618 | 35,390 | |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 60.00 | 23,350 | 1,401,000 | 0 | 23.4 K to 0 (-100.00 %) |
| Jul 13 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 25.08 | 23,350 | 585,618 | 23,350 | 0 to 23.4 K |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 25.08 | 6,885 | 172,676 | 57,177 | |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 22.06 | 60,937 | 1,344,270 | 6,250 | |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 9.50 | 16,029 | 152,276 | 0 | |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 7.00 | 1,191 | 8,337 | 0 | |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 7.00 | 8,350 | 58,450 | 0 | |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 56.61 | 4,493 | 254,349 | 0 | 4.5 K to 0 (-100.00 %) |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 55.83 | 46,478 | 2,594,867 | 4,493 | 51 K to 4.5 K (-91.19 %) |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 54.94 | 42,421 | 2,330,610 | 50,971 | 93.4 K to 51 K (-45.42 %) |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 25.08 | 6,885 | 172,676 | 6,885 | 0 to 6.9 K |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 22.06 | 60,937 | 1,344,270 | 60,937 | 0 to 60.9 K |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 9.50 | 16,029 | 152,276 | 16,029 | 0 to 16 K |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 7.00 | 1,191 | 8,337 | 1,191 | 0 to 1.2 K |
| Jun 28 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 7.00 | 8,350 | 58,450 | 8,350 | 0 to 8.4 K |
| Mar 16 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 8.50 | 4,300 | 36,550 | 0 | |
| Mar 16 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 7.00 | 5,935 | 41,545 | 8,350 | |
| Mar 16 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 40.02 | 10,235 | 409,605 | 0 | 10.2 K to 0 (-100.00 %) |
| Mar 16 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 8.50 | 4,300 | 36,550 | 4,300 | 0 to 4.3 K |
| Mar 16 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 7.00 | 5,935 | 41,545 | 5,935 | 0 to 5.9 K |
| Mar 03 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 38.61 | 5,334 | 205,946 | 50,767 | 56.1 K to 50.8 K (-9.51 %) |
| Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP and CFO | Option Exercise | A | 0.00 | 15,625 | 0 | 15,625 | |
| Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP and CFO | Option Exercise | A | 25.54 | 62,500 | 1,596,250 | 62,500 | |
| Feb 01 2017 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | EVP and CFO | Grant | A | 0.00 | 15,625 | 0 | 15,625 | 0 to 15.6 K |
| Aug 01 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 3.30 | 15,152 | 50,002 | 0 | |
| Aug 01 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 3.30 | 15,152 | 50,002 | 15,152 | 0 to 15.2 K |
| May 03 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | A | 23.76 | 32,500 | 772,200 | 32,500 | |
| May 03 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 16,250 | 0 | 16,250 | 0 to 16.3 K |
| Mar 04 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Payment of Exercise | F | 31.75 | 1,524 | 48,387 | 10,476 | 12 K to 10.5 K (-12.70 %) |
| Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | A | 0.00 | 13,750 | 0 | 13,750 | |
| Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | A | 33.49 | 55,000 | 1,841,950 | 55,000 | |
| Jan 29 2016 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Grant | A | 0.00 | 13,750 | 0 | 13,750 | 0 to 13.8 K |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 9.00 | 5,000 | 45,000 | 0 | |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 5.10 | 978 | 4,988 | 0 | |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 5.10 | 2,934 | 14,963 | 0 | |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 55.00 | 8,912 | 490,160 | 0 | 8.9 K to 0 (-100.00 %) |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 9.00 | 5,000 | 45,000 | 8,912 | 3.9 K to 8.9 K (+127.81 %) |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 5.10 | 978 | 4,988 | 3,912 | 2.9 K to 3.9 K (+33.33 %) |
| Sep 21 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 5.10 | 2,934 | 14,963 | 2,934 | 0 to 2.9 K |
| Jun 09 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 4.10 | 12,195 | 50,000 | 0 | |
| Jun 09 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 5.00 | 3,924 | 19,620 | 0 | |
| Jun 09 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 43.00 | 16,119 | 693,117 | 0 | 16.1 K to 0 (-100.00 %) |
| Jun 09 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 4.10 | 12,195 | 50,000 | 16,119 | 3.9 K to 16.1 K (+310.78 %) |
| Jun 09 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 5.00 | 3,924 | 19,620 | 3,924 | 0 to 3.9 K |
| May 27 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 5.00 | 6,076 | 30,380 | 3,924 | |
| May 27 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 41.00 | 6,076 | 249,116 | 0 | 6.1 K to 0 (-100.00 %) |
| May 27 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 5.00 | 6,076 | 30,380 | 6,076 | 0 to 6.1 K |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 9.50 | 13,290 | 126,255 | 0 | |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 37.88 | 13,290 | 503,452 | 0 | 13.3 K to 0 (-100.00 %) |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 9.50 | 13,290 | 126,255 | 13,290 | 0 to 13.3 K |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 9.50 | 9,151 | 86,935 | 13,290 | |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 7.00 | 4,523 | 31,661 | 1,191 | |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 38.21 | 13,674 | 522,511 | 0 | 13.7 K to 0 (-100.00 %) |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 9.50 | 9,151 | 86,935 | 13,674 | 4.5 K to 13.7 K (+202.32 %) |
| May 12 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 7.00 | 4,523 | 31,661 | 4,523 | 0 to 4.5 K |
| Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 4.10 | 3,454 | 14,161 | 0 | |
| Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Option Exercise | M | 5.00 | 2,238 | 11,190 | 0 | |
| Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Sell | S | 39.95 | 5,692 | 227,395 | 0 | 5.7 K to 0 (-100.00 %) |
| Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 4.10 | 3,454 | 14,161 | 5,692 | 2.2 K to 5.7 K (+154.33 %) |
| Feb 23 2015 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Executive VP and CF ... | Buy | M | 5.00 | 2,238 | 11,190 | 2,238 | 0 to 2.2 K |
| Mar 27 2014 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Senior VP and CFO | Option Exercise | A | 25.08 | 75,000 | 1,881,000 | 75,000 | |
| Mar 27 2014 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Senior VP and CFO | Sell | S | 25.69 | 5,000 | 128,433 | 29,824 | 34.8 K to 29.8 K (-14.36 %) |
| Nov 07 2013 | PTLA | PORTOLA PHARMACEUT ... | Dier Mardi | Senior VP and CFO | Option Exercise | A | 22.06 | 75,000 | 1,654,500 | 75,000 |
Page: 1